Targeting NF-κB in hematologic malignancies

Haroon Khan, Hammad Ullah, Paula C. Castilho, Antonio García‐Ríos, Grazia D’Onofrio, Rosanna Filosa, Fang Wang, Seyed Mohammad Nabavi, Maria Daglia, A. Sanches‐Silva, Kannan R. R. Rengasamy, Juanying Ou, Xiaobo Zou, Jianbo Xiao, Hui Cao

Article2020

Epitranscriptomics in Hematopoiesis and Hematologic Malignancies

Margalida Rosselló-Tortella, Gerardo Ferrer, Manel Esteller

Article1993

New initiatives with fludarabine monophosphate in hematologic malignancies.

Michael J. Keating, Susan O’Brien, L. E. Robertson, Hagop M. Kantarjian, Meletios A Dimopoulos, Peter McLaughlin, Fernando Cabanillas, V. Grégoire, Liuqing Yang, Varsha Gandhi

Article1994

The Expanding Role of Fludarabine in Hematologic Malignancies

Michael J. Keating, Susan O’Brien, Lester E. Robertson, Hagop M. Kantarjian, Meletios A Dimopoulos, Peter McLaughlin, Fernando Cabanillas, V. Grégoire, Li Ying-Yang, Varsha Gandhi, Elihu H. Estey, William Plunkett

Article1994

Fludarabine phosphate: a new active agent in hematologic malignancies.

Michael J. Keating, Susan O’Brien, William Plunkett, L. E. Robertson, Varsha Gandhi, Elihu H. Estey, Meletios A Dimopoulos, Fernando Cabanillas, A. Kemena, Hagop M. Kantarjian